TwitterLinkedinTelegramTelegram
Marcia BradyOther - United States23-Apr-2026
Compared with e.g. lentiviruses, adenovirus DNA does not integrate into the host genome but remains episomal.
Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
Marcia BradyOther - United States25-Mar-2026
The Recombinant Human CD7 (C-6His) is produced in our Human Cell expression system. The amino acid region expressed is Ala26-Pro180 with a 6His tag at the C terminus.

Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
Marcia BradyOther - United States12-Feb-2026
CRISPR/Cas9 PlatformCB is a professional genetic editing biotechnology company that provides transgenic mouse models for biomedical research and drug discovery. We will provide you with a one-stop-shop from experimental design strategies to successful mouse model generation.

Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
Marcia BradyOther - United States19-Dec-2025
The overexpression of proteins is critical for many applications, including studying the function of the gene, and in functional assays and screens. Mammalian cells offer advantages in post-translational modification and protein.

Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
Marcia BradyOther - United States24-Nov-2025
CRISPR/Cas9 PlatformCB is a professional genetic editing biotechnology company that provides transgenic mouse models for biomedical research and drug discovery.
Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
Marcia BradyOther - United States27-Oct-2025
QVirus Platform offers a comprehensive portfolio of oncolytic VACV services for the efficient design, development, manufacturing and analytical testing of virus vector products. So far, we have developed an efficient way to generate recombinant VACVs, including inserting and/or deleting GOI(s) in VACVs. We also provide customized oncolytic vaccinia virus and proof-of-concept validation study for the oncolytic virus.

Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
Marcia BradyOther - United States18-Aug-2025
As a global leader in VLP technology services, Creative Biogene leverages over a decade of technical expertise, international GMP production qualifications, and a comprehensive service system to provide end-to-end solutions for research institutions and pharmaceutical companies—from basic research to industrial production, accelerating the clinical translation and commercialization of innovative therapies.

Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
Marcia BradyOther - United States18-Aug-2025
Creative Biogene, leveraging cutting-edge virology technology platforms, provides pseudovirus construction and customization services covering various viral families. These services support viral function research, vaccine evaluation, neutralizing antibody detection, and antiviral drug screening. Our pseudovirus technology offers a safe and efficient solution for your research and development work.

Likecomment
share
My favorites